Founder of Zogenix, Inc., Jonathan M. N. Rigby is a British businessperson who has been at the helm of 6 different companies and currently is Chairman & Chief Business Officer at BioPlus Acquisition Corp. and President, Group CEO & Director at Revolo Biotherapeutics Ltd.

He is also on the board of Thermalin, Inc. and ImmunoMolecular Therapeutics, Inc. and Chairman at Association of Needle-Free Injection Manufacturers.

In the past Mr. Rigby held the position of Chairman for CollPlant Biotechnologies Ltd., Principal at Merck & Co., Inc., Vice President-Business Development for Aradigm Corp., President, Chief Executive Officer & Director at SteadyMed Therapeutics, Inc., President, Chief Executive Officer & Director at SteadyMed Ltd., Vice President-Business Development of Zogenix, Inc. and Head-Business Development & Sales at Respironics Ltd.

He received an undergraduate degree from The University of Sheffield and an MBA from the University of Portsmouth.